Anika Therapeutics Price to Book Ratio 2006-2021 | ANIK

Historical price to book ratio values for Anika Therapeutics (ANIK) over the last 10 years. The current price to book ratio for Anika Therapeutics as of October 15, 2021 is 2.10.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Anika Therapeutics Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-10-15 41.66 2.09
2021-06-30 43.29 $19.89 2.18
2021-03-31 40.79 $19.26 2.12
2020-12-31 45.26 $19.01 2.38
2020-09-30 35.39 $20.02 1.77
2020-06-30 37.73 $20.31 1.86
2020-03-31 28.91 $20.69 1.40
2019-12-31 51.85 $20.16 2.57
2019-09-30 54.89 $19.74 2.78
2019-06-30 40.62 $18.20 2.23
2019-03-31 30.24 $18.93 1.60
2018-12-31 33.61 $18.56 1.81
2018-09-30 42.18 $17.96 2.35
2018-06-30 32.00 $16.91 1.89
2018-03-31 49.72 $17.89 2.78
2017-12-31 53.91 $17.94 3.01
2017-09-30 58.00 $17.28 3.36
2017-06-30 49.34 $16.66 2.96
2017-03-31 43.44 $15.70 2.77
2016-12-31 48.96 $15.23 3.21
2016-09-30 47.85 $14.67 3.26
2016-06-30 53.65 $13.83 3.88
2016-03-31 44.72 $13.23 3.38
2015-12-31 38.16 $14.02 2.72
2015-09-30 31.83 $13.31 2.39
2015-06-30 33.03 $12.70 2.60
2015-03-31 41.17 $12.12 3.40
2014-12-31 40.74 $11.99 3.40
2014-09-30 36.66 $11.47 3.20
2014-06-30 46.33 $10.97 4.22
2014-03-31 41.10 $10.71 3.84
2013-12-31 38.16 $9.49 4.02
2013-09-30 23.89 $8.99 2.66
2013-06-30 17.00 $8.52 2.00
2013-03-31 14.52 $8.06 1.80
2012-12-31 9.94 $7.86 1.27
2012-09-30 15.02 $7.50 2.00
2012-06-30 13.59 $7.32 1.86
2012-03-31 12.54 $7.14 1.76
2011-12-31 9.80 $6.95 1.41
2011-09-30 5.44 $6.82 0.80
2011-06-30 7.12 $6.69 1.06
2011-03-31 8.96 $6.49 1.38
2010-12-31 6.67 $6.32 1.06
2010-09-30 6.01 $6.26 0.96
2010-06-30 5.89 $5.92 0.99
2010-03-31 7.11 $6.04 1.18
2009-12-31 7.63 $6.12 1.25
2009-09-30 6.50 $5.62 1.16
2009-06-30 4.75 $5.47 0.87
2009-03-31 4.59 $5.36 0.86
2008-12-31 3.04 $5.34 0.57
2008-09-30 7.22 $5.22 1.38
2008-06-30 8.59 $5.08 1.69
2008-03-31 8.48 $4.99 1.70
2007-12-31 14.55 $4.90 2.97
2007-09-30 20.81 $4.71 4.42
2007-06-30 15.19 $4.52 3.36
2007-03-31 12.37 $4.34 2.85
2006-12-31 13.27 $4.22 3.14
2006-09-30 13.33 $4.10 3.25
2006-06-30 9.68 $3.92 2.47
2006-03-31 12.22 $3.76 3.25
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.601B $0.130B
Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative cartilage repair. Anika's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00